ASCENDIS HEALTH LIMITED - Dealings in securities by an associate of directors

Dealings in securities by an associate of directors

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis” or “the Company”)

Dealings in securities by an associate of directors

In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by an associate of directors, is disclosed:


 Directors:                           Gary Shayne and Crispian Dillon

 Name of Associate and                Coast2Coast Capital Proprietary Limited (“C2C”), through a
 description of the transaction:      subsidiary, is transferring Ascendis shares in settlement of the
                                      redemption of a debenture issued by it on 20 May 2016, at a
                                      price per share determined using the pre-agreed pricing
                                      mechanism for the debenture.

 Date of transaction:                 6 March 2018

 Class of shares:                     Ordinary shares

 Number of shares:                    553,230

 Price per share:                     R25.21

 Value:                               R13,946,928.30

 Nature of transaction:               Sale, off market

 Nature and extent of interest:       Indirect beneficial (through C2C, in which directors Gary
                                      Shayne and Crispian Dillon have an 85% and 15% indirect
                                      beneficial interest, respectively).

 Written clearance obtained:          Clearance was obtained from the Chairman


Bryanston
6 March 2018

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 06/03/2018 11:24:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.